Newsroom
23 press releases and 54 media coverage stories
BioProcess International: ScaleReady launches $20m advanced therapy grant program
BioProcess International
ScaleReady, in collaboration with Wilson Wolf, Bio-Techne, and CellReady, has launched a ‘G-Rex®’ grant program aimed at advancing CGTs.
Read the article : BioProcess International: ScaleReady launches $20m advanced therapy grant programShare: BioProcess International: ScaleReady launches $20m advanced therapy grant program
The Medicine Maker: Introducing the Experts
The Medicine Maker
Industry leaders are uniting to drive the future of cell and gene therapy manufacturing. Experts like Josh Ludwig of ScaleReady are at the forefront of implementing automation and digital solutions to overcome complex challenges in the sector. From streamlining operations to accelerating time-to-market, these advancements are poised to revolutionize the industry.
Read the article : The Medicine Maker: Introducing the ExpertsShare: The Medicine Maker: Introducing the Experts
Fierce Pharma: Automation, decentralization and the future of CAR-Ts: Advancements in cell & gene therapy manufacturing
Fierce Pharma
The final installment of "The Top Line" series dives deep into the cutting-edge world of cell and gene therapy manufacturing. Join host Fraiser Kansteiner, Josh Ludwig and other industry experts as they explore innovative production approaches and discuss how to overcome the challenges of bringing these life-saving therapies to market.
Read the article : Fierce Pharma: Automation, decentralization and the future of CAR-Ts: Advancements in cell & gene therapy manufacturingShare: Fierce Pharma: Automation, decentralization and the future of CAR-Ts: Advancements in cell & gene therapy manufacturing
BioProcess International: CAR-T Therapy Manufacturing Lessons from the Automotive Industry
BioProcess International
CAR-T therapy has promise but manufacturing is slow and expensive. In this article, ScaleReady's Josh Ludwig suggests CAR-T manufacturing can learn from the auto industry's assembly-line approach to improve efficiency and make these therapies more accessible.
Read the article : BioProcess International: CAR-T Therapy Manufacturing Lessons from the Automotive IndustryShare: BioProcess International: CAR-T Therapy Manufacturing Lessons from the Automotive Industry
Drug Discovery World: Looking Ahead for Cell and Gene Therapy
Drug Discovery World
Drug Discovery World discusses the future of the cell and gene therapy sector with industry experts, including ScaleReady’s Josh Ludwig, who predict what to expect in 2024 and beyond.
Read the article : Drug Discovery World: Looking Ahead for Cell and Gene TherapyShare: Drug Discovery World: Looking Ahead for Cell and Gene Therapy
Pharma’s Almanac: What Strategies Accelerate Time-to-market Without Compromising Quality?
Pharma's Almanac
In this edition of the Pharma's Almanac quarterly roundtable questionnaire, industry experts, including Josh Ludwig, Global Director of ScaleReady, discuss the increasing pressure to reduce time-to-market. The share strategies to accelerate product development and commercialization without compromising quality.
Read the article : Pharma’s Almanac: What Strategies Accelerate Time-to-market Without Compromising Quality?Share: Pharma’s Almanac: What Strategies Accelerate Time-to-market Without Compromising Quality?
Pharma’s Almanac: How Can Biopharma Demonstrate Its Commitment to ESG in Manufacturing?
Pharma's Almanac
In this edition of the Pharma's Almanac quarterly roundtable questionnaire, industry experts, including Josh Ludwig, Global Director of ScaleReady, discuss how pharmaceutical and biopharmaceutical companies can demonstrate their commitment to ESG principles in manufacturing.
Read the article : Pharma’s Almanac: How Can Biopharma Demonstrate Its Commitment to ESG in Manufacturing?Share: Pharma’s Almanac: How Can Biopharma Demonstrate Its Commitment to ESG in Manufacturing?
BioSpace: How Cell and Gene Therapy Manufacturing Will Evolve in 2024
BioSpace
Key figures at Phacilitate’s Advanced Therapies Week emphasized the power of sharing knowledge to create standardized, scalable processes in cell and gene therapy manufacturing. ScaleReady is proud to embrace this approach, especially in our partnership with Luminary Therapeutics.
Read the article : BioSpace: How Cell and Gene Therapy Manufacturing Will Evolve in 2024Share: BioSpace: How Cell and Gene Therapy Manufacturing Will Evolve in 2024
Phacilitate: Navigating the Nuances of Process and Analytical Development for Decentralized Production
Phacilitate
Decentralized manufacturing models, where therapies are produced closer to the patient show promise. But the path from research to this decentralized model, while maintaining rigorous Good Manufacturing Practice (GMP) compliance, is anything but easy. In a recent panel discussion, Josh Ludwig shed light on this complex transition.
Read the article : Phacilitate: Navigating the Nuances of Process and Analytical Development for Decentralized ProductionShare: Phacilitate: Navigating the Nuances of Process and Analytical Development for Decentralized Production
The Medicine Maker: The Future of Cell and Gene Therapy Innovation
The Medicine Maker
While cell and gene therapy represent a captivating frontier, ongoing innovation and adaptation to Industry 4.0 principles are essential for progress. In this feature, experts, including Josh Ludwig, Global Director of ScaleReady, delve into the definitions of Industry 4.0 and its implications for the present and future of cell and gene therapy manufacturing.
Read the article : The Medicine Maker: The Future of Cell and Gene Therapy InnovationShare: The Medicine Maker: The Future of Cell and Gene Therapy Innovation
Drug Discovery World: Josh Ludwig Discusses Industry Trends and Predictions for 2024
Drug Discovery World
In this issue of Drug Discovery World, Megan Thomas spoke with industry experts about the opportunities and challenges that lie ahead in 2024. Josh Ludwig, Global Director, Commercial Operations at…
Read the article : Drug Discovery World: Josh Ludwig Discusses Industry Trends and Predictions for 2024Share: Drug Discovery World: Josh Ludwig Discusses Industry Trends and Predictions for 2024
Pharma Manufacturing: 2024 Pharma Predictions
Pharma Manufacturing
The upcoming year promises significant changes driven by historic successes and economic challenges in 2023. Notable events mark the industry's current juncture of innovation and adjustment. Industry leaders, including ScaleReady's Josh Ludwig, predict trends for 2024, including the transformative impact of AI in drug development and key regulatory changes to monitor.
Read the article : Pharma Manufacturing: 2024 Pharma PredictionsShare: Pharma Manufacturing: 2024 Pharma Predictions
